Delivery Order SPE2DB20D3101-SPE2DB24FRUN6

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,641.63, is for the delivery of the drug Loryna 3 mg-0.02 mg tablet in quantities of 28 tablets. The contract is a Firm Fixed Price Delivery Order, with a completion date of November 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,032.64 firm fixed-price delivery order is for the supply of the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S, with an ultimate completion date of October 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,885.32 firm fixed-price delivery order is for the supply of LORYNA 3 MG-0.02 MG tablets. The contract has an ultimate completion date of April 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,378.00, is a delivery order for the medication Loryna 3 mg-0.02 mg tablet 28s. The contract is a firm fixed-price arrangement without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,797.40 firm fixed-price delivery order is for the supply of LORYNA 3 MG-0.02 MG TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,102.34 firm-fixed-price delivery order is for the supply of the medication LORYNA 3 MG-0.02 MG TABLET 28S. The contract has an ultimate completion date of August 22, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $1,432.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LORYNA 3 MG-0.02 MG tablets, a pharmaceutical product, with an ultimate completion date of July 25, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and it was awarded on July 24, 2024. There is no set-aside designation for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,102.84, is a Firm Fixed Price Delivery Order for the medication Loryna 3 mg-0.02 mg tablet, 28 count. The contract has an ultimate completion date of January 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,003.20, is a firm fixed-price delivery order for the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S. The contract has an ultimate completion date of November 7, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a comprehensive range of medical products to federal agencies, particularly within...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,868.95 Firm Fixed Price delivery order is for the supply of the drug Loryna, a 3 mg-0.02 mg tablet product. The contract has an ultimate completion date of July 22, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRUN6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,616.67 Firm Fixed Price Delivery Order contract is for the supply of the generic drug Loryna 3 mg-0.02 mg tablet, 28 count. The contract has a completion date of September 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This contract award does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:04 AM